Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvest Mi (di) Regulatory News (HMI)

Share Price Information for Harvest Mi (di) (HMI)

Share Price is delayed by 15 minutes
Get Live Data
0.275    0.00 (0.00%)
Bid:
0.25
Ask:
0.30
Spread: 0.05 (20.00%)
Market Cap: £1.38m
HMI Live PriceLast checked at - London Stock Exchange

Intraday Harvest Mi (di) Share Chart

£1,000,000 Equity Issue and TVR

2 Jul 2024 07:15

RNS Number : 7640U
Harvest Minerals Limited
02 July 2024
 

 

02 July 2024

Harvest Minerals Limited

("Harvest" or the "Company")

 

£1,000,000 Equity Issue and TVR

 

Harvest Minerals Limited, the AIM listed organic fertilizer producer, is pleased to announce an equity issue package consisting of a placing ("Placing") that has raised gross proceeds of c. £425,000, and the settlement of c. £575,000 of director / company secretary fees, through the issue of, in aggregate, 100,000,000 new ordinary shares of no par value at a price of 1p ("Issue Price") (the "Equity Issue").

 

The Placing was undertaken by the Company's broker, Tavira Financial Limited ("Tavira").

 

Use of Proceeds

The net funds raised from the Placing will be used to continue with the advancement of the Arapua Project, in particular to carry out further drilling and testwork to better delineate the potential of the Rare Earth Elements ("REE") identified and to meet ongoing working capital requirements, both operationally as sales of KP Fertil advance, and corporately.

 

Issue of Settlement Shares

 

The Equity Issue included the issue of, in aggregate, 57,736,600 new Ordinary Shares to three of the four Board members, and to Palisade Business Consulting, which provides the Company with accounting and company secretary services, as settlement for all fees outstanding to the various parties up until 30 June 2024. As has been previously disclosed, Jack James is a director and shareholder of Palisade Business Consulting:

 

Person

Fees Owed (£)

No. of Settlement Shares issued

Brian McMaster

286,000

28,600,000

Luis Azevedo

160,000

16,000,000

Jack James

28,311

2,831,100

Palisade Business Consulting (PBC)

103,055

10,305,500

Total

577,366

57,736,600

 

 

Following the issue of the Settlement Shares, and the shares issued pursuant to the Placing, the Directors holdings will be as below:

 

 

 

Shareholdings

 

Director

Position

Current

Holding

Settlement Shares

Holding on Admission

 

% on

Admission

Brian McMaster

Executive Chairman

7,242,996

28,600,000

35,842,996

12.4%

Luis Azevedo

Non-Executive Director

1,645,135

16,000,000

17,645,135

6.1%

Jack James, inc. PBC

Non-Executive Director

Nil

13,135,200

13,135,200

4.5%

 

Brian McMaster, Executive Chairman commented:

"This is the first time Harvest has raised equity in over 6 years, being a testament to the robustness of the core business. The opportunity to explore for REE is an interesting development and we look forward to reporting results in the coming months. The Board welcomes new shareholders to the register and as a sign of further support the board has converted substantial sums to equity, improving our balance sheet position."

Related Party Transaction

The issue of the Settlement Shares constitutes a related party transaction under AIM Rule 13 of the AIM Rules for Companies. Alex Penha, as the independent director of the Company for the purposes of this transaction, considers, having consulted with the Company's Nominated Adviser, that the terms of the issue of the Settlement Shares are fair and reasonable insofar as the Company's shareholders are concerned.

 

Application to trading on AIM

 

The Equity Issue is conditional on Admission. Application will be made to the London Stock Exchange for the 100,000,000 new Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 5 July 2024 ("Admission").

 

Total Voting Rights

 

Following the Equity Issue, the total issued share capital of the Company will consist of 289,169,217 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in treasury and accordingly there are no voting rights in respect of any treasury shares. 

 

On Admission, the abovementioned figure of 289,169,217 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Harvest under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Harvest Minerals Limited

 

Brian McMaster (Chairman)

 

Tel: +44 (0) 203 940 6625

 

Strand Hanson Limited (Nominated & Financial Adviser)

Ritchie Balmer

James Spinney

 

 

Tel: +44 (0) 20 7409 3494

Tavira Financial

(Broker)

Jonathan Evans

Tel: +44 (0) 20 3192 1733

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUUANRSRUBRRR
Date   Source Headline
7th Apr 20267:00 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSHolding(s) in Company
17th Mar 20267:00 amRNSHolding(s) in Company
17th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20267:00 amRNSBoard Change
17th Feb 202612:01 pmRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
30th Sep 20258:31 amRNSInterim Results
14th Aug 20259:30 amRNSResults of AGM
14th Jul 20257:00 amRNSNotice of AGM
10th Jul 20251:56 pmRNSHolding(s) in Company
30th Jun 20252:10 pmRNSIssue of Settlement Shares and TVR
26th Jun 202511:26 amRNSFinal Results
23rd Jun 20257:00 amRNSFundraise of £300,000
19th Jun 20257:00 amRNSUpdate on Rare Earth Exploration
16th Jun 20257:00 amRNSSales and Corporate Update
17th Mar 20257:00 amRNSKP Fértil® Sales and Corporate Update
11th Nov 202411:15 amRNSPositive Assay Results at the Arapuá Project
30th Sep 20247:53 amRNSHalf-year Report
16th Sep 20247:00 amRNSAgreement to Further Advance REE at Arapua
8th Aug 202410:20 amRNSResult of AGM
16th Jul 20247:50 amRNSCommencement of REE Exploration Programme
10th Jul 20247:00 amRNSHolding(s) in Company
5th Jul 20247:00 amRNSNotice of AGM
2nd Jul 20247:15 amRNS£1,000,000 Equity Issue and TVR
26th Jun 202411:42 amRNSFinal Results
2nd May 20241:45 pmRNSKP Fértil® Sales Update
10th Apr 20249:01 amRNSOccurrences of REE at the Arapuá Project
10th Apr 20249:00 amRNSQ1 2024 KP Fértil® Sales Update
15th Feb 20241:11 pmRNSFull Year 2023 KP Fértil® Sales & 2024 Guidance
23rd Oct 20237:00 amRNSQ3 2023 KP Fértil® Sales Update
21st Sep 20237:32 amRNSHalf-year Report
17th Aug 202312:30 pmRNSResult of AGM
14th Aug 20237:00 amRNSTrading Statement
17th Jul 20237:00 amRNSNotice of AGM
30th Jun 20237:00 amRNSQ2 & H1 2023 KP Fértil® Sales Update
30th Jun 20237:00 amRNSFinal Results
18th Apr 20237:00 amRNSQ1 2023 KP Fértil® Sales Update
14th Feb 20239:00 amRNSTrading Update
14th Feb 20238:55 amRNSPositive Court Ruling
26th Jan 20237:00 amRNSInvestor Presentation
24th Jan 20237:54 amRNSQ4 & Full Year 2022 Sales & 2023 Guidance
7th Dec 20222:05 pmRNSSecond Price Monitoring Extn
7th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Oct 20229:17 amRNSNew Corporate Presentation
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
30th Sep 202210:13 amRNSInvestor Presentation
29th Sep 202211:07 amRNSClarification on H1 2022 Sales Orders
29th Sep 20229:06 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.